Taking over-the counter sleep aids when you are older might not be such a good idea, as sleep pills increase dementia risk, as confirmed by yet another study. A report connects high use of anticholinergic medications – including prominent prescription -free sleep pills and the antihistamine Benadryl (diphenhydramine) to an expanded risk of dementia and Alzheimer’s in older individuals.
Anticholinergics are a class of medication that hinders the activity of the neurotransmitter acetylcholine. This can prompt numerous reactions, including tiredness, constipation, urine retention and dry mouth and eyes.
The analysts behind the study, drove by Shelly Gray, from the University of Washington School of Pharmacy in Seattle, presented the result of the research in JAMA Internal Medicine. The researchers, led by Shelly Gray, a professor in the University of Washington School of Pharmacy in Seattle, report their findings in JAMA Internal Medicine.
Prof. Shelly Gray does not recommend people to stop their treatment based on the discoveries of this study. Instead, they ought to talk with their physician, and let them know about all their over-the-counter medication they purchase and intake.
The connection between high risk of dementia and anticholinergics had already been discovered prior to this recent study, but the new findings are based on more thorough techniques and was carried over a long period of time, respectively 7 years. By reviewing drug store records, the scientists were likewise capable to incorporate prescription free anticholinergics in their date.
It is additionally the first research to uncover a dose- reaction impact, note the scientists. That is, the higher the aggregate medication taken, the higher the danger of developing dementia.
Another premiere for the study is that it likewise demonstrates that dementia risk connected to anticholinergics may persist long after individuals quit taking the medications.
For their research, Prof. Ash and associates monitored almost 3,500 men and ladies aged 65 and over with no dementia signs at the beginning of the study. The subjects were part of the Adult Changes in Thought (ACT) study in Group Health, a combined health care delivery framework in Seattle.
To evaluate the exposure the patients had to anticholinergic medications, the specialists utilized digital records from the drug stores that apportioned them. Over the time of the study, almost 800 subjects developed dementia. The findings demonstrated that the most commonly used pharmaceuticals were tricyclic antidepressants, original antihistamines and antimuscarinics for bladder control. The scientists assessed that individuals taking no less than 10 mg every day of doxepin, 4 mg every day of chlorpheniramine, or 5 mg every day of oxybutynin for over 3 years would be at more severe risk of suffering from dementia.
A part of the ACT patients have consented to have their brains autopsied after death. This may uncover if taking anticholinergic medicines is more likely to lead to brain changes that are normal for individuals who develop Alzheimer’s.The research was funded by NIH’s National Institute on Aging and the Branta Foundation.
Image Source: The Guardian